This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Khora Spv 1, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Robert Kania
Introduction
Robert Kania is an accomplished inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of inhibitors for fibroblast growth factor receptor kinases. His work is crucial for advancing treatments for various diseases.
Latest Patents
Robert Kania holds a patent for "Inhibitors of fibroblast growth factor receptor kinases." This patent includes heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising these compounds, and methods for using them in the treatment of diseases. He has 1 patent to his name, showcasing his innovative approach to addressing medical challenges.
Career Highlights
Kania is currently associated with Khora SPV 1, LLC, where he continues to push the boundaries of pharmaceutical research. His expertise in the field has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Throughout his career, Robert has collaborated with notable professionals, including Stephen W. Kaldor and John Tyhonas. These partnerships have enhanced his research and contributed to the development of effective therapeutic solutions.
Conclusion
Robert Kania's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the development of fibroblast growth factor receptor kinase inhibitors are paving the way for new treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile